PUBLISHER: 360iResearch | PRODUCT CODE: 1600689

PUBLISHER: 360iResearch | PRODUCT CODE: 1600689

Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Global Forecast 2025-2030

PUBLISHED: October 31, 2024

PAGES: 196 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Cystatin C Assay Market was valued at USD 427.47 million in 2023, expected to reach USD 459.83 million in 2024, and is projected to grow at a CAGR of 7.24%, to USD 697.41 million by 2030.

A Cystatin C Assay is a medical diagnostic tool used to measure levels of cystatin C, a protein that reflects kidney function, providing a more accurate assessment than traditional creatinine tests. The necessity of this assay lies in its ability to offer earlier and precise information about declining renal function, making it essential in applications such as chronic kidney disease (CKD) monitoring, cardiovascular risk assessment, and research in nephrology. The end-use scope encompasses hospitals, diagnostic laboratories, and research institutes. The market is primarily driven by the rising prevalence of CKD, an aging population, and increasing demand for accurate diagnostics. Key influencing growth factors include advancements in assay technologies, heightened awareness about kidney health, and the integration of cystatin C testing within routine health check-ups. Latest opportunities are seen in emerging markets where healthcare infrastructure is improving and in regions witnessing a higher incidence of CKD due to lifestyle factors. Additionally, the development of combination assays that integrate genetic markers and cystatin C could tap into personalized medicine trends.

KEY MARKET STATISTICS
Base Year [2023]	USD 427.47 million
Estimated Year [2024]	USD 459.83 million
Forecast Year [2030]	USD 697.41 million
CAGR (%)	7.24%

However, challenges like high costs, lack of awareness among medical professionals in developing regions, and variability in assay results due to non-standardized testing methods can impede market growth. Innovations are necessary in areas such as cost reduction through technological advances and enhancement of assay speed and accuracy. Investing in education and training for healthcare providers in emerging markets could better identify and promote the assay's benefits, broadening its adoption. The market is currently competitive and fragmented, driven by constant innovation and regulatory challenges, but opportunities for expansion exist through collaborations with biotech firms and focus on portable or point-of-care testing solutions. Overall, expanding applications in early diagnosis and chronic disease management will sustain and enhance market trajectory.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystatin C Assay Market

The Cystatin C Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Rising prevalence of kidney diseases and growing geriatric population
- Progressive investments in healthcare infrastructures for renal disorders
Market Restraints
- High development costs of cystatin C assays and incidences of product recalls
Market Opportunities
- Advances in cystatin C assay testing
- Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
Market Challenges
- Dearth of skilled lab professionals and technical challenges associated with cystatin C assay

Porter's Five Forces: A Strategic Tool for Navigating the Cystatin C Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystatin C Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystatin C Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystatin C Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystatin C Assay Market

A detailed market share analysis in the Cystatin C Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystatin C Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystatin C Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor - Laboratorni medicina a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystatin C Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Analyzer, Kits, and Reagents.
Based on Method, market is studied across Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay, Particle-enhanced Nephelometric Immunoassay, and Particle-enhanced Turbidimetric Immunoassay.
Based on Sample Type, market is studied across Blood and Urine.
Based on Setting, market is studied across Laboratory Setting and Point of Care Setting.
Based on Application, market is studied across Diagnosis Use and Research & Development.
Based on End-user, market is studied across Academic Research Centers, Diagnostic Laboratories, and Hospitals & Clinics.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-2E76C3E47F4F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
  - 5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
- 5.1.2. Restraints
  - 5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
- 5.1.3. Opportunities
  - 5.1.3.1. Advances in cystatin C assay testing
  - 5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
- 5.1.4. Challenges
  - 5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
5.2. Market Segmentation Analysis
- 5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
- 5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
- 5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
- 5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
- 5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
- 5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Cystatin C Assay Market, by Product

6.1. Introduction
6.2. Analyzer
6.3. Kits
6.4. Reagents

7. Cystatin C Assay Market, by Method

7.1. Introduction
7.2. Chemiluminescence Immunoassay
7.3. Enzyme linked Immunosorbent Assay
7.4. Immunofluorescence Assay
7.5. Particle-enhanced Nephelometric Immunoassay
7.6. Particle-enhanced Turbidimetric Immunoassay

8. Cystatin C Assay Market, by Sample Type

8.1. Introduction
8.2. Blood
8.3. Urine

9. Cystatin C Assay Market, by Setting

9.1. Introduction
9.2. Laboratory Setting
9.3. Point of Care Setting

10. Cystatin C Assay Market, by Application

10.1. Introduction
10.2. Diagnosis Use
10.3. Research & Development

11. Cystatin C Assay Market, by End-user

11.1. Introduction
11.2. Academic Research Centers
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics

12. Americas Cystatin C Assay Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Cystatin C Assay Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Cystatin C Assay Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
- 15.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
- 15.3.2. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
- 15.3.3. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
- 15.3.4. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
- 15.3.5. New European Cystatin C Equation for eGFR May Be More Accurate
- 15.3.6. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
- 15.3.7. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
- 15.3.8. Bloom Diagnostics Launches New Kidney Test

Companies Mentioned

1. Abbexa Limited
2. Abbott Laboratories
3. Abcam PLC
4. Advy Chemical Pvt. Ltd.
5. Agilent Technologies, Inc.
6. AOBIOUS Inc.
7. Arbor Assays Inc.
8. Aviva Systems Biology Corporation
9. BBI Solutions OEM Limited
10. Bio-Rad Laboratories, Inc.
11. Bio-Techne Corporation
12. Biorbyt Ltd
13. BioVendor - Laboratorni medicina a.s.
14. Boditech Med Inc.
15. Cepham Life Sciences, Inc.
16. Cusabio Technology LLC
17. DIALAB GmbH
18. DiaSys Diagnostic Systems GmbH
19. Diazyme Laboratories, Inc. by General Atomics
20. Eagle Biosciences, Inc.
21. Elabscience Biotechnology Inc.
22. Ethos Biosciences, Inc.
23. Eurolyser Diagnostica GmbH by Mars, Incorporated
24. F. Hoffmann-La Roche Ltd
25. Fapon Biotech Inc.
26. Fortress Diagnostics Ltd.
27. Gentian Diagnostics ASA
28. Getein Biotech, Inc.
29. ImmunoDiagnostics Limited
30. Kamiya Biomedical Company
31. Laboratory Corporation of America Holdings
32. Merck KGaA
33. Proteintech Group, Inc.
34. PZ CORMAY S.A.
35. Randox Laboratories Ltd.
36. RayBiotech, Inc.
37. Sekisui Diagnostics, LLC
38. Siemens Healthineers AG
39. Sino Biological, Inc.
40. Thermo Fisher Scientific Inc.
41. Tosoh Corporation
42. Weldon Biotech
43. Zhejiang Kangte Biotechnology Co., Ltd.

Product Code: MRR-2E76C3E47F4F

LIST OF FIGURES

FIGURE 1. CYSTATIN C ASSAY MARKET RESEARCH PROCESS
FIGURE 2. CYSTATIN C ASSAY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 6. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 18. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 20. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 22. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 26. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. CYSTATIN C ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 6. CYSTATIN C ASSAY MARKET DYNAMICS
TABLE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 19. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 20. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 21. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 22. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 23. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 24. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 25. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 26. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 27. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 28. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 29. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 30. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 31. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 32. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 33. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 34. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 35. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 36. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 37. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 38. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 39. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 40. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 41. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 42. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 43. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 44. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 45. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 46. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 47. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 48. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 49. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 50. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 51. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 52. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 53. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 54. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 55. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 56. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 57. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 58. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 59. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 60. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 61. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 62. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 63. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 64. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 65. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 66. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 67. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
TABLE 68. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 69. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 70. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 71. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 72. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 73. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 74. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 75. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 76. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 77. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 78. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 79. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 80. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 81. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 82. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 83. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 84. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 85. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 86. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 87. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 88. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 89. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 90. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 91. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 92. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 93. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 94. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 95. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 96. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 97. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 98. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 99. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 100. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 101. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 102. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 103. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 104. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 105. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 106. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 107. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 108. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 109. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 110. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 111. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 112. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 113. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 114. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 115. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 116. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 117. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 118. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 119. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 120. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 121. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 122. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 123. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 124. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 125. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 126. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 127. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 128. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 129. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 130. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 131. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 132. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 133. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 134. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 135. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 136. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 137. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 138. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 139. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 140. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 141. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 142. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 143. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 144. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 145. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 146. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 154. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 155. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 156. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 157. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 158. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 159. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 160. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 161. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 162. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 163. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 164. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 165. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 166. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 167. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 168. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 169. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 170. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 171. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 172. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 173. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 174. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 175. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 176. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 177. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 178. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 179. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 180. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 181. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 182. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 183. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 184. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 185. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 186. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 187. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 188. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 189. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 190. ITALY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 191. ITALY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 192. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 193. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 194. ITALY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 195. ITALY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 196. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 197. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 198. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 199. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 200. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 201. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 202. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 203. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 204. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 205. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 206. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 207. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 208. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 209. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 210. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 211. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 212. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 213. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 214. POLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 215. POLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 216. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 217. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 218. POLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 219. POLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 220. QATAR CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 221. QATAR CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 222. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 223. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 224. QATAR CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 225. QATAR CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 226. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 227. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 228. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 229. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 230. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 231. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 232. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 233. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 234. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 235. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 236. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 237. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 238. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 239. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 240. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 241. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 242. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 243. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 244. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 245. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 246. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 247. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 248. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 249. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 250. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 251. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 252. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 253. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 254. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 255. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 256. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 257. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 258. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 259. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 260. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 261. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 262. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 263. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 264. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 265. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 266. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 267. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 268. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 269. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 270. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 271. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 272. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 273. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 274. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 275. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 276. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 277. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 278. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 279. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 280. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ